AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Loriglyme-G1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lorioxindia Pharmaceuticals Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Loriglyme-G1 Tablet PR

GlycoDuo-RX tablets are anti-diabetic medications combining two agents to manage type 2 diabetes in adults. They help regulate blood glucose. GlycoDuo-RX should be taken with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication even if feeling well; abrupt cessation can elevate blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any heart history before commencing treatment. Pregnant or breastfeeding individuals should consult their physician. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be necessary.

Uses of Loriglyme-G1 Tablet PR

Managing type 2 diabetes

Major Benefits of Loriglyme-G1 Tablet PR:

Follow your doctor's instructions or consult the product label for guidance before administering. Take Loriglyme-G1 Tablet PR with a meal.

Common Side effects of Loriglyme-G1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Loriglyme-G1 Tablet PR:

Follow your doctor's instructions or refer to the product label for dosage information. Administer Loriglyme-G1 Tablet PR with food.

How Loriglyme-G1 Tablet PR works:

Loriglyme-G1 PR tablets contain glimepiride and metformin, a dual-action antidiabetic regimen. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Loriglyme-G1 Tablet PR and alcohol is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Loriglyme-G1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Loriglyme-G1 Tablet PR. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Loriglyme-G1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Loriglyme-G1 Tablet PR is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Loriglyme-G1 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, Loriglyme-G1 Tablet PR is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Loriglyme-G1 Tablet PR :

Should you forget a Loriglyme-G1 Tablet PR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Loriglyme-G1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Loriglyme-G1 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Loriglyme-G1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Loriglyme-G1 Tablet PR and seek immediate medical attention.
Loriglyme-G1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Loriglyme-G1 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Loriglyme-G1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Loriglyme-G1 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Loriglyme-G1 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Loriglyme-G1 Tablet PR
52
MRP 60
13% off